|
Real-time
OTC Markets
15:57:58 03/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
-22.00% | -87.61% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-13 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 3.15M 2.71M 2.54M 2.32M 4.34M 297M 4.37M 30.04M 11.7M 152M 11.81M 11.55M 489M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25M 21.51M 20.18M 18.47M 34.47M 2.36B 34.74M 239M 92.99M 1.21B 93.88M 91.83M 3.89B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.09% | ||
| 1 week | -22.00% | ||
| Current month | -18.25% | ||
| 1 month | -18.37% | ||
| 3 months | -2.05% | ||
| 6 months | -51.16% | ||
| Current year | -87.61% |
| 1 week | 0.11 |  | 0.15 |
| 1 month | 0.11 | | 0.17 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 2.49 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.1 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 20/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 15/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 31/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 31/03/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 20/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 20/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 18/03/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 18/03/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | -22.00% | -95.48% | -95.12% | 3.15M | |
| -1.10% | -2.63% | +53.94% | +104.89% | 1,034B | |
| -0.69% | +3.11% | +54.61% | +72.01% | 671B | |
| -1.14% | +0.71% | +20.80% | +76.11% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.30% | +1.48% | +56.67% | +72.76% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.23% | +3.56% | +33.78% | +100.72% | 188B | |
| Average | -0.96% | +1.14% | +15.99% | +37.34% | 371.68B | |
| Weighted average by Cap. | -0.90% | +1.04% | +36.60% | +66.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.55M 23.04M 21.08M 39.35M 2.7B 39.66M 273M 106M 1.38B 107M 105M 4.44B | 20.71M 17.82M 16.72M 15.3M 28.56M 1.96B 28.78M 198M 77.04M 1B 77.78M 76.08M 3.22B |
| Net income | -39.26M -33.78M -31.7M -29M -54.13M -3.71B -54.56M -375M -146M -1.9B -147M -144M -6.11B | -48.06M -41.35M -38.8M -35.5M -66.26M -4.54B -66.79M -459M -179M -2.32B -180M -177M -7.48B |
| Net Debt | 6.05M 5.21M 4.88M 4.47M 8.34M 572M 8.41M 57.79M 22.5M 292M 22.72M 22.22M 941M | 21.85M 18.8M 17.65M 16.14M 30.13M 2.07B 30.37M 209M 81.29M 1.06B 82.07M 80.28M 3.4B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | US$0.1530 | +13.33% | 669 |
| 02/09/26 | US$0.1350 | +4.81% | 1,498 |
| 31/08/26 | US$0.1288 | -.--% | 141 |
| 28/08/26 | US$0.1288 | -4.59% | 1,688 |
| 27/08/26 | US$0.1350 | +4.81% | 137 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
